Vimian Group AB (publ) (VIMGF)

Market Cap	1.94B
Revenue (ttm)	388.03M
Net Income (ttm)	19.15M
Shares Out	n/a
EPS (ttm)	0.04
PE Ratio	101.04
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	6,327
Open	3.500
Previous Close	3.885
Day's Range	3.500 - 3.500
52-Week Range	2.250 - 4.120
Beta	1.58
RSI	45.50
Earnings Date	Feb 13, 2025

About Vimian Group AB

Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the I...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2020
• Employees: 1,100
• Stock Exchange: OTCMKTS
• Ticker Symbol: VIMGF

Financial Performance

In 2024, Vimian Group AB's revenue was 374.80 million, an increase of 12.98% compared to the previous year's 331.73 million. Earnings were 18.50 million, an increase of 88.01%.

Financial numbers in EUR